Blunted Cardiovascular Growth Induction During Prolonged Nitric Oxide Synthase Blockade

Hypertension

Volumn 30, Issue 3, 1997, Pages 416-421

  Banting, James D ^a   Thompson, Karen E ^a   Friberg, Peter ^a   Adams, Michael A ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; ORNITHINE; ORNITHINE DECARBOXYLASE;

ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENZYME INHIBITION; HEART LEFT VENTRICLE FUNCTION; HYPERTENSION; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE;

ANIMALS; ARTERIES; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; ENZYME INHIBITORS; HINDLIMB; MALE; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; ORGAN SIZE; ORNITHINE DECARBOXYLASE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VASCULAR RESISTANCE;

EID: 0030753355     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.30.3.416     Document Type: Article

References (33)

1. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347-504.
2. Griffin SA, Brown WCB, MacPherson F, McGrath JC, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991;17:626-635.
3. 1 receptor. Am J Cardiol. 1992;62:30G-35G.
4. Arnal JF, Warin L, Michel J-B. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest. 1992;90:647-652.
5. Arnal JF, El Amrani AI, Chatellier G, Menard J, Michel J-B. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension. 1993;22:380-387.
6. Delacretaz E, Hayoz D, Osterheld MC, Genton CY, Brunner HR, Waeber B. Long-term nitric oxide synthase inhibition and distensibility of carotid artery in intact rats. Hypertension. 1994;23[pt 2]:967-970.
7. Jover B, Herizi A, Ventre F, Dupont M, Mimram A. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension. 1993;21:944-948.
8. Fernandez-Rivas A, Garcia-Estan J, Vargas F. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension. J Hypertens. 1995;13:123-128.
9. Sventek P, Li JS, Grove K, Deschepper CF, Schiffrin EL. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats. Hypertension. 1996;27:49-55.
10. Dunn WR, Gardiner SM. No evidence for vascular remodelling during hypertension induced by chronic inhibition of nitric oxide synthase in Brattleboro rats. J Hypertens. 1995;13:849-857.
11. G-nitro-L-arginine methyl ester-induced hypertension: methodological considerations for studies of small arteries in hypertension. J Hypertens. 1995;13:817-821. Editorial.
12. omega -nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats. J Hypertens. 1996;14:1331-1340.
13. Banting JD, Friberg P, Adams MA. Hypertension following nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J Hypertens. 1996;14:975-981.
14. Richard V, Hogie M, Clozel M, Loffler BM, Thuillez C. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation. 1995;91:771-775.
15. Weber H, Webb ML, Serafino R, Taylor DS, Moreland S, Molloy CJ. Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signalling mechanisms. Mol Endocrinol. 1994;8:148-158.
16. Schiffrin EL, Lariviere R, Li JS, Sventek P, Touyz RM. Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. Hypertension. 1995;25(pt 2):769-773.
17. Thyberg J, Fredholm BB. Modulation of arterial smooth muscle cells from contractile to synthetic phenotype requires induction of ornithine decarboxylase activity and polyamine synthesis. Exp Cell Res. 1987;170:153-159.
18. Davis RH. Management of polyamine pools and the regulation of ornithine decarboxylase. J Cell Biochem. 1990;44:199-205.
19. Soltis EE, Newman PS, Olson JW. Polyamines, vascular smooth muscle, and deoxycorticosterone acetate-salt hypertension. Hypertension. 1991;18:85-92.
20. Russell D, Synder SH. Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tissues. Proc Natl Acad Sci U S A. 1968;60:1420-1427.
21. Thompson KE, Adams MA. Differential effect of short term ethanol on cardiac and vascular growth responses. J Hypertens. 1994;12:409-418.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin reagent. J Biol Chem. 1951;193:265-275.
23. Folkow B, Hallback M, Lundgren Y, Weiss L. Background of increased flow resistance and vascular reactivity in spontaneously hypertensive rats. Acta Physiol Scand. 1970;80:93-106.
24. Li JS, Schiffrin EL. Resistance artery structure and neuroeffector mechanisms in hypertension induced by nitric oxide synthase. Am J Hypertens. 1994;7:996-1004.
25. Banting JD, Lundie MJ, Morales A, Ge SP, Adams MA, Heaton JPW. Isolation and perfusion of the pudendal vasculature in male rats. J Urol. 1995;154:587-590.
26. Adams MA, Bobik A, Korner PI. Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats. Hypertension. 1990;16:252-260.
27. Marquardt DW. An algorithm for least-squares estimates of nonlinear parameters. Soc Ind Appl Math. 1963;11:431-441.
28. Head GA, Adams MA. Time course of changes in baroreceptor reflex control of heart rate in conscious SHR and WKY: contribution of the cardiac vagus and sympathetic nerves. Clin Exp Pharmacol Physiol. 1988;15:289-292.
29. Lever AF. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens. 1986,4:515-524.
30. Bank N, Aynedjian S, Kahn GA. Mechanism of vasoconstriction induced by chronic inhibition of nitric oxide in rats. Hypertension. 1994;24:322-328.
31. Auvinen M, Paasinen A, Andersson LC, Holtta E. Ornithine decarboxylase activity is critical for cell transformation. Nature. 1992;360:355-358.
32. Pegg AE, Shantz LM, Coleman CS. Ornithine decarboxylase: structure, function and translational regulation. Biochem Soc Trans. 1994;22:846-852.
33. Pedersen SB, Flyvbjerg A, Richelsen B. Inhibition of renal ornithine decarboxylase activity prevents kidney hypertrophy in experimental diabetes. Cell Physiol. 1993;33:C453-C456.